Copper Peptide · Copper Tripeptide-1 · GHK Copper
GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-complexed tripeptide found in human plasma, saliva, and urine. Plasma levels decline significantly with age, from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60. GHK-Cu plays a central role in extracellular matrix remodeling, collagen synthesis, antioxidant defense, and gene expression regulation. It delivers copper to lysyl oxidase, the enzyme responsible for cross-linking collagen types I and III into durable, organized fibers. GHK-Cu is discussed in the context of skin rejuvenation, wound healing, tissue remodeling, hair growth support, and as a component of multi-peptide repair protocols (GLOW and KLOW blends). The copper ion is integral to its function but creates specific syringe mixing considerations.
Draw FIRST in multi-compound syringes (mechanical contamination prevention - copper transfer to needle hub can oxidize partner-vial peptides on later piercings). Inject immediately after drawing. Best administered in the evening/bedtime. No fasting required.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
GHK-Cu delivers bioavailable copper(II) to lysyl oxidase and other copper-dependent enzymes critical for collagen cross-linking, elastin formation, and extracellular matrix integrity. Beyond its copper delivery role, GHK-Cu directly modulates gene expression, upregulating genes involved in tissue repair (collagen, decorin, metalloproteinases) while suppressing genes associated with inflammation and tissue destruction. It stimulates synthesis of collagen types I, III, and V, elastin, glycosaminoglycans, and proteoglycans. GHK-Cu also participates in redox homeostasis by regulating copper-dependent antioxidant enzymes (superoxide dismutase) and modulating iron metabolism. The tripeptide structure confers cell-penetrating ability, allowing intracellular gene expression effects beyond surface receptor signaling.
Days 1-14: Minimal visible changes. GHK-Cu works through gene expression changes that take time to manifest in new protein synthesis. Injection tolerance is typically good.
Weeks 2-6: Skin texture and firmness improvements begin to appear. Wound healing acceleration becomes noticeable if recovering from injury or procedure. Hair quality changes may begin.
Weeks 6-12: Cumulative collagen and elastin synthesis produces visible skin improvements. Tissue remodeling effects become apparent. Scar tissue softening reported. Best results at 8-12 weeks of consistent use.
Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.
GHK-Cu promoted skin remodeling, healing, and regeneration and showed antioxidant/anti-inflammatory effects.
GHK-Cu has been shown to promote skin remodeling, wound healing and regeneration, and has prominent antioxidant and anti-inflammatory effects in in vitro and in vivo studies.
The potential of GHK as an anti-aging peptide.
Evidence scope. Review; preclinical, not controlled SubQ human data.
Claims we could not support
No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.
Dose/route: 1-2.5 mg SubQ daily or 5-on/2-off. No checked human abstract administered this regimen.
Injection reactions, discoloration, and copper safety. No same-route clinical abstract established these.
Anti-aging / skin rejuvenation
Human topical studies support improvement in skin thickness, fine lines, and firmness. Gene expression data shows broad anti-aging gene activation. One of the better-supported anti-aging claims for any peptide, at least topically.
Animal and in vitro data show hair follicle enlargement and stem cell activation. Anecdotal human reports support this. Not a validated hair loss treatment.
Microarray studies show GHK-Cu modulates approximately 4,000 human genes, many toward a younger expression pattern. This is well-documented in vitro data. In vivo significance at injectable doses is extrapolated.
Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.
Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.
SubQ
Gene expression changes persist well beyond peptide clearance
Enzymatic degradation (rapid peptidase cleavage; copper ion redistributed to ceruloplasmin and albumin)
Storage. Store unreconstituted vials frozen (-20C) or refrigerated (2-8C). After reconstitution, refrigerate at 2-8C. Stable for 28-30 days. Copper complex provides some structural stability. Solution may have slight blue tint (normal). Discard if cloudy or particles visible. Protect from light.
GHK-Cu is available as a research peptide and through compounding pharmacies. Not FDA-approved for any indication. WADA status is not specifically addressed (unlikely to be tested for). Available in various topical cosmetic formulations without prescription.
Put it to work
Open GHK-Cu straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open GHK-Cu in the app →Go deeper
The complete GHK-Cu walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗Track it in OnePin. Log vials, draws, and protocols in the app.
Type a name, brand, or tool. Esc closes.